List of works - John G Hay

"Man's best friend": a new model system for cancer therapeutics?

article

A novel cell-penetrating peptide to facilitate intercellular transport of fused proteins

scientific article

Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury

scientific article published on 01 January 2008

Drug evaluation: Reolysin--wild-type reovirus as a cancer therapeutic.

scientific article published on June 2006

Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria.

scientific article published on September 2016

Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity.

scientific article published on 21 December 2010

Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators

scientific article published on 01 September 2002

How do changes in tumor matrix affect the outcome of virotherapy?

scientific article published on 08 February 2007

Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus.

scientific article

Impact of E1a modifications on tumor-selective adenoviral replication and toxicity.

scientific article published on October 2004

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points

scientific article published on March 2003

Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein

scientific article published on 01 October 2002

Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.

scientific article published on 10 February 2006

New Drug for Sepsis on the Cheap?

scientific article published in July 2015

Sindbis virus--an effective targeted cancer therapeutic.

scientific article published in October 2004

The potential impact of hypoxia on the success of oncolytic virotherapy.

scientific article

List of works by John G Hay

"Man's best friend": a new model system for cancer therapeutics?

A novel cell-penetrating peptide to facilitate intercellular transport of fused proteins

Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury

Drug evaluation: Reolysin--wild-type reovirus as a cancer therapeutic.

Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria.

Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity.

Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators

How do changes in tumor matrix affect the outcome of virotherapy?

Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus.

Impact of E1a modifications on tumor-selective adenoviral replication and toxicity.

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points

Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein

Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.

New Drug for Sepsis on the Cheap?

Sindbis virus--an effective targeted cancer therapeutic.

The potential impact of hypoxia on the success of oncolytic virotherapy.